Erratum to: Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer

被引：0
|
作者：
Philip Q. Bao
Ramesh K. Ramanathan
Alyssa Krasinkas
Nathan Bahary
Barry C. Lembersky
David L. Bartlett
Steven J. Hughes
Kenneth K. Lee
A. James Moser
Herbert J. Zeh
机构：
[1] Stony Brook University Hospital,Department of Surgery
[2] Virginia G. Piper Cancer Center,Department of Pathology
[3] University of Pittsburgh Medical Center,Department of Medical Oncology
[4] University of Pittsburgh Medical Center,Department of Surgery, Division of Surgical Oncology
[5] University of Pittsburgh Medical Center,undefined
来源：
Annals of Surgical Oncology | 2011年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：323 / 323
相关论文
共 50 条
  • [11] A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer
    El-Rayes, Bassel Fuad
    Philip, Philip A.
    Sarkar, Fazlul H.
    Shields, Anthony F.
    Ferris, Ann Marie
    Hess, Kenneth
    Kaseb, Ahmad O.
    Javle, Milind M.
    Varadhachary, Gauri R.
    Wolff, Robert A.
    Abbruzzese, James L.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (04) : 694 - 699
  • [12] A phase II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JS']JSAP-03)
    Saiura, Akio
    Ueno, Hideki
    Kosuge, Tomoo
    Matsuyama, Yutaka
    Ishii, Hiroshi
    Nakao, Akimasa
    Doi, Ryuichiro
    Tanaka, Masao
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [13] A phase II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese study group of adjuvant therapy for pancreatic cancer (JS']JSAP-03)
    Ishii, Hiroshi
    Ueno, Hideki
    Kosuge, Tomoo
    Matsuyama, Yutaka
    Saiura, Akio
    Koga, Rintaro
    Sakamoto, Yoshihiro
    Shimada, Kazuaki
    Nakao, Akimasa
    Doi, Ryuichiro
    Tanaka, Masao
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [14] A Randomized Phase II Trial of Adjuvant Chemotherapy With Uracil/Tegafur and Gemcitabine Versus Gemcitabine Alone in Patients With Resected Pancreatic Cancer
    Yoshitomi, Hideyuki
    Togawa, Akira
    Kimura, Fumio
    Ito, Hiroshi
    Shimizu, Hiroaki
    Yoshidome, Hiroyuki
    Otsuka, Masayuki
    Kato, Atsushi
    Nozawa, Satoshi
    Furukawa, Katsunori
    Miyazaki, Masaru
    CANCER, 2008, 113 (09) : 2448 - 2456
  • [15] Phase II trial of postoperative adjuvant gemcitabine and cisplatin chemotherapy followed by chemoradiation with gemcitabine in patients with resected pancreatic cancer.
    Kwon, J. H.
    Chie, E. K.
    Kim, J. H.
    Im, S.
    Oh, D.
    Kim, Y.
    Han, S.
    Lee, K.
    Jang, J.
    Kim, T.
    Kim, J. S.
    Han, H. S.
    Kim, S.
    Yoon, Y. B.
    Bang, Y.
    Ha, S. W.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [16] A phase II study of gemcitabine, erlotinib and S-1 in patients with advanced pancreatic cancer
    Han, Boram
    Kim, Bum Jun
    Kim, Hyeong Su
    Choi, Dae Ro
    Shim, Byoung Yong
    Lee, Kyung Hee
    Kim, Jin Won
    Kim, Jung Han
    Song, Hunho
    Kim, Jong Hyeok
    Park, Choong Kee
    Lee, Jung Woo
    Kim, Min-Jeong
    Zang, Dae Young
    JOURNAL OF CANCER, 2021, 12 (03): : 912 - 917
  • [17] A phase I/II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JS']JSAP-03)
    Ishii, H.
    Ueno, H.
    Kosuge, T.
    Matsuyama, Y.
    Saiura, A.
    Nakao, A.
    Doi, R.
    Tanaka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [18] CONKO-005: Adjuvant therapy in R0 resected pancreatic cancer patients with gemcitabine plus erlotinib versus gemcitabine for 24 weeks-A prospective randomized phase III study
    Sinn, Marianne
    Liersch, Torsten
    Gellert, Klaus
    Messmann, Helmut
    Bechstein, Wolf O.
    Waldschmidt, Dirk
    Jacobasch, Lutz
    Wilhelm, Martin
    Rau, Bettina M.
    Gruetzmann, Robert
    Weinmann, Arndt
    Maschmeyer, Georg
    Pelzer, Uwe
    Stieler, Jens
    Striefler, Jana Kaethe
    Ghadimi, B. Michael
    Bahra, Marcus
    Oettle, Helmut
    Doerken, Bernd
    Riess, Hanno
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [19] Gemcitabine Adjuvant Therapy for Resected Pancreatic Cancer A Meta-analysis
    Yu, Zhong
    Zhong, Wa
    Tan, Zhi-Ming
    Wang, Ling-Yun
    Yuan, Yu-Hong
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (03): : 322 - 325
  • [20] A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
    H Ueno
    T Kosuge
    Y Matsuyama
    J Yamamoto
    A Nakao
    S Egawa
    R Doi
    M Monden
    T Hatori
    M Tanaka
    M Shimada
    K Kanemitsu
    British Journal of Cancer, 2009, 101 : 908 - 915
12345